| Name | Title | Contact Details |
|---|---|---|
Joseph Vittiglio |
Executive Vice President and General Counsel at AMAG Pharmaceuticals, Inc. | Profile |
Helen Milton |
SVP, Head of Regulatory Affairs | Profile |
James Accumanno |
Associate General Counsel | Profile |
Lisa-Beth Meletta |
Exec. Dir., Associate General Counsel | Profile |
Tracy Berns |
Chief Compliance Officer | Profile |
Tolerx is a Cambridge, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Cannabis Science is a Colorado Springs, CO-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Bioinformatics.org is a Framingham, MA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Genizon BioSciences Inc. is a Saint-Laurent, QC-based company in the Healthcare, Pharmaceuticals, & Biotech sector.
Avanir Pharmaceuticals, Inc. is a biopharmaceutical company focused on bringing innovative medicines to patients with central nervous system disorders of high unmet medical need. As part of our commitment, we have extensively invested in our pipeline and are dedicated to advancing medicines that can substantially improve the lives of patients and their loved ones. Avanir is a subsidiary of Otsuka America, Inc. (OAI), a holding company established in the U.S. in 1989. OAI is wholly owned by Otsuka Pharmaceutical Co., Ltd. The Otsuka Group employs approximately 42,000 people globally, and its products are available in more than 80 countries worldwide.